SCHEMBL8038516

SCHEMBL8038516

COC(=O)c1c(CC(C)C)nc(-c2ccc(Cl)cc2)nc1NC1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.39
TSHR P16473 2/20 0.39
HPGD P15428 1/20 0.39
PLA2G1B P04054 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SLC6A3 Q01959 3/20 0.36
PDE5A O76074 2/20 0.36
ACP1 P24666 2/20 0.36
CNR1 P21554 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8037126 0.90 PLA2G1B (0.41) NPSR1TSHRHPGDPLA2G1BATG4B
SCHEMBL8040669 0.85 NPSR1 (0.42) NPSR1TSHRHPGDADORA3KDM4E
SCHEMBL8039494 0.84 VCP (0.39) NPSR1TSHRHPGDKDM4EALDH1A1
SCHEMBL8040303 0.82 NPSR1 (0.42) NPSR1TSHRHPGDKDM4EALDH1A1
SCHEMBL8041741 0.82 NPSR1 (0.42) NPSR1TSHRHPGDADORA3KDM4E
SCHEMBL8038367 0.81 SMN1; SMN2 (0.40) NPSR1TSHRHPGDADORA3KDM4E
SCHEMBL8034844 0.80 CASP3 (0.46) NPSR1TSHRPLA2G1BATG4BADORA3
SCHEMBL8032664 0.80 CNR2 (0.42) NPSR1TSHRHPGDADORA3KDM4E
SCHEMBL8034467 0.78 CNR1 (0.44) SLC6A3CNR1NAMPT
SCHEMBL8043493 0.77 PLA2G1B (0.45) NPSR1PLA2G1BATG4BADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080242-A1 SUBSTITUTED 4-AMINOPYRIMIDINE-5-CARBOXYLIC ACID AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed